home / stock / govxw / govxw news

GOVXW News and Press, GeoVax Labs Inc. Warrants From 01/05/21

Stock Information
Company Name: GeoVax Labs Inc. Warrants
Stock Symbol: GOVXW
Market: NASDAQ
Website: geovax.com
Menu
GOVXW GOVXW Quote GOVXW Short GOVXW News GOVXW Articles GOVXW Message Board
Get GOVXW Alerts

News, Short Squeeze, Breakout and More Instantly...
GOVXW - GeoVax to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference

GeoVax Also Participating in BIO@JPM During “J.P. Morgan Week 2021” ATLANTA, GA, Jan. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc . (NasdaqCM: GOVX), a biotechnology company developing vaccines and immunotherapies against infecti...
GOVXW - GeoVax Announces License Agreement With NIH to Support Continued Advancements in Vaccine Development

Atlanta, GA, Nov. 30, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX, GOVXW) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cance...

GOVXW - GeoVax Reports 2020 Third Quarter Financial Results and Provides Corporate Update

Public Offering Completed in September 2020 Provides Resources to Accelerate COVID-19 Vaccine and Immuno-Oncology Programs ATLANTA, GA, Nov. 05, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX, GOVXW), a biotechnology company developing imm...

GOVXW - GeoVax to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update

Conference call to be held Friday, November 6, at 8:15 a.m. Eastern Time ATLANTA, GA, Oct. 30, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX, GOVXW) (“GeoVax” or the “Company”), a biotechnology company de...
GOVXW - GeoVax CEO David Dodd to Participate in Virtual Webinar Hosted by Outsourced Pharma

ATLANTA, GA, Oct. 28, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX, GOVXW) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, tod...

GOVXW - GeoVax Announces License Agreement with NIH to Support COVID-19 Vaccine Development

ATLANTA, GA, Oct. 26, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (NasdaqCM: GOVX, GOVXW) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, t...

Previous 10 Next 10